Deutsche Bank Bullish On Biogen: New Data Doesn't Change Probability Of Success For Alzheimer's
July 22, 2015 at 16:16 PM EDT
In a report issued Wednesday, Deutsche Bank analysts Robyn Karnauskas, Mohit Bansal and Evan Seigerman maintained a Buy rating and ...